CACI International Director Scott C. Morrison Acquires 85 Shares via RSU Vesting on July 13, 2026

Details of the July 13, 2026 RSU Vesting Transaction for Scott C. Morrison

According to the disclosure filed on July 15, 2026, Scott C. Morrison, identified as a director of CACI International Inc. /DE/, acquired 85 shares of CACI common stock on July 13, 2026. The transaction code recorded in the filing is "M," which is the standard designation for the conversion or exercise of a derivative security, in this case the vesting of Restricted Stock Units into common shares. The acquisition was made directly, with no indirect beneficial ownership arrangement noted for this transaction.

Prior to this transaction, the filing does not separately state Morrison's pre-transaction share count, but following the reported acquisition of 85 shares, his total directly held beneficial ownership in CACI common stock stood at 584 shares. The price column for the acquisition of common stock through the RSU vesting is footnoted, indicating the shares were received pursuant to the terms of the RSU grant rather than through an open-market purchase at a disclosed cash price. The company did not disclose a per-share acquisition price separate from the RSU grant terms.

Original RSU Grant Terms and Four-Tranche Vesting Schedule

The filing's explanatory footnote provides important context for understanding how the July 13, 2026 vesting fits into the broader equity compensation picture for Morrison as a director. On October 16, 2025, Morrison was granted a total of 338 Restricted Stock Units. These RSUs were structured to vest in four separate tranches over approximately one year from the grant date, with each tranche tied to a specific calendar date.

The vesting schedule disclosed in the filing is as follows: 84 shares vested on January 14, 2026; 84 shares vested on April 14, 2026; 85 shares vested on July 13, 2026 (the transaction reported in this filing); and a final tranche of 85 shares is scheduled to vest on October 11, 2026. The filing confirms that the July 13, 2026 vesting represents the third of four tranches under this grant, with the cumulative shares vested to date under this specific award totaling 253 shares across the first three tranches combined.

Remaining Derivative Securities and Outstanding RSU Position

Table II of the disclosure addresses Morrison's derivative securities position. At the time of the July 13, 2026 transaction, Morrison held 85 Restricted Stock Units in derivative form prior to the vesting event. Following the conversion of those 85 RSUs into 85 shares of common stock on July 13, 2026, the remaining number of RSUs beneficially owned by Morrison under this grant is reported as 85, which corresponds directly to the final outstanding tranche scheduled to vest on October 11, 2026.

The filing identifies the derivative security as Restricted Stock Units, with the underlying security being CACI common stock, with each RSU representing one share. The ownership form for Morrison's remaining RSU position is listed as direct. The price of the derivative security upon conversion is noted with a footnote reference consistent with the grant terms rather than a separate disclosed cash value. The company did not disclose any additional RSU grants or separate derivative positions beyond those described in this filing.

Scott C. Morrison's Role and Relationship to CACI International

The disclosure identifies Scott C. Morrison as a director of CACI International Inc. /DE/, which is listed on NASDAQ under the ticker CACI. Morrison's address is listed as 12021 Sunset Hills Road, Reston, Virginia 20190, which corresponds to CACI's corporate headquarters address. The filing confirms that Morrison filed the disclosure individually, rather than as part of a joint or group filing involving multiple reporting persons.

The filing indicates that Morrison's relationship to the issuer is solely as a director, with no indication of a 10% ownership position or officer designation checked in the applicable section of the disclosure. This is consistent with standard equity compensation arrangements for non-executive board members, whereby RSU grants represent a component of director remuneration. The filing does not provide additional biographical detail or describe any other roles Morrison may hold beyond his directorship.

Cumulative Beneficial Ownership Following the Third Tranche Vesting

With the vesting of the third tranche, Morrison's total direct beneficial ownership in CACI common stock is now reported at 584 shares as of the July 13, 2026 transaction date. This figure reflects all securities beneficially owned by Morrison following the reported transaction, as required under the applicable reporting instructions. The filing does not separately enumerate shares held prior to the October 2025 RSU grant, so investors should note that the 584-share total represents the cumulative directly held position as disclosed at this point in time.

The beneficial ownership figure of 584 shares represents a relatively modest stake in CACI International, a company with a significantly larger share count outstanding. The filing does not provide data on Morrison's ownership as a percentage of total shares outstanding, nor does it reference any open-market purchases or sales of CACI common stock by Morrison separate from the RSU-related transactions described. The immediate share price impact of this transaction was not clear from available public information.

How RSU-Based Director Compensation Reflects Corporate Governance Practices

The structure of Morrison's RSU grant — 338 units vesting in four roughly equal quarterly tranches over approximately one year — is characteristic of equity compensation programs designed to align director interests with those of long-term shareholders. By distributing vesting events across multiple quarters, such arrangements incentivize continued board service and ongoing engagement with the company's performance over the duration of the vesting period rather than providing a single lump-sum equity award.

RSU grants to non-executive directors are a widely used form of equity compensation in corporate governance, and their disclosure under Section 16(a) of the Securities Exchange Act of 1934 is a routine requirement for directors, officers, and 10% beneficial owners of publicly listed companies. The filing is consistent with standard practice for reporting RSU vesting events, with each tranche triggering a separate disclosure obligation at the time of conversion from derivative to common stock. CACI International did not release any separate commentary on the compensation structure in connection with this disclosure.

Section 16 Reporting Obligations and the Disclosure Timeline

The statement of changes in beneficial ownership was filed on July 15, 2026, two days after the transaction date of July 13, 2026. Section 16(a) of the Securities Exchange Act of 1934 generally requires insiders — including directors — to report changes in beneficial ownership of the issuer's equity securities within two business days of the transaction. The filing confirms it was submitted by one reporting person and that Morrison signed the document on July 15, 2026.

The filing carries an OMB approval number and the standard reminder that intentional misstatements or omissions of facts in such filings constitute federal criminal violations under 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). The disclosure does not indicate any amendment to a previously filed report, nor does it check the box indicating that the reporting person is no longer subject to Section 16 reporting obligations, confirming Morrison's continued status as a director subject to ongoing disclosure requirements.

CACI International's Broader Context as a Government Technology Contractor

CACI International Inc. is a Reston, Virginia-based company listed on NASDAQ that provides information technology and professional services, primarily to the United States federal government. The company operates across defense, intelligence, and civilian government markets. The filing does not contain any financial results, revenue figures, contract awards, or forward-looking guidance, and this article does not go beyond the scope of the disclosed transaction.

Director equity compensation disclosures such as this one are a routine element of the transparency framework applicable to NASDAQ-listed companies. Investors and analysts who track insider ownership changes as part of their research process may note the continued accumulation of common shares by Morrison through scheduled RSU vestings, with one additional tranche of 85 shares remaining under the October 2025 grant. Beyond the vesting schedule already disclosed, the filing contains no information about future equity grants or compensation decisions.

What Remains Outstanding Under the October 2025 RSU Grant

As of the July 13, 2026 vesting, three of the four tranches under Morrison's October 16, 2025 RSU grant have been converted into shares of CACI common stock. The cumulative shares converted from this grant total 253 shares across the first three tranches (84 shares on January 14, 2026; 84 shares on April 14, 2026; and 85 shares on July 13, 2026). The remaining balance under the grant is 85 RSUs, which the filing states are scheduled to vest on October 11, 2026.

The filing does not indicate any conditions, performance requirements, or acceleration provisions that might affect the final vesting tranche beyond the calendar date of October 11, 2026. It also does not reference any forfeiture events, departures from the board, or other circumstances that could alter the vesting of the remaining units. The company did not disclose any additional details beyond the vesting schedule and transaction data contained in the filing itself.